Remove keyword chronic-kidney-disease
article thumbnail

Grand Rounds Ethics and Regulatory Series February 10, 2023: Informing and Consenting: What Are the Goals? (P. Pearl O’Rourke, MD; David S. Wendler, PhD, MA; Miguel Vazquez, MD; P. Michael Ho, MD, PhD)

Rethinking Clinical Trials

ICD-Pieces studied patients with chronic kidney disease (CKD), diabetes and hypertension. If you are notifying, when do you offer an opt-out option and what do you do when potential subjects have questions or do not want to be in the research? The intervention was to facilitate delivery of guideline-based care.

article thumbnail

Grand Rounds September 16, 2022: Using Nationwide Registries to Conduct Pragmatic Randomized Trials: The DANFLU Program (Tor Biering-Sørensen, MD, PhD, MPH)

Rethinking Clinical Trials

The DECODE trial used registry data to identify patients with chronic kidney disease. These one-time interventions, like vaccines, contact people, deliver intervention, what about chronic care that is needed for a trial where more monitoring is needed? Faculty of Health and Medical Sciences. University of Copenhagen.

Trials 130